Variant report
Variant | esv3363705 |
---|---|
Chromosome Location | chr4:90077429-90079827 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:90079815..90080591-chr4:90355230..90356029,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7672894 | chr4:90077431-90077432 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs375471785 | chr4:90077471-90077472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141676108 | chr4:90077475-90077476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs57987710 | chr4:90077522-90077523 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs567968519 | chr4:90077562-90077563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189815835 | chr4:90077590-90077591 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs78860683 | chr4:90077595-90077596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115044622 | chr4:90077600-90077601 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550461473 | chr4:90077621-90077622 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557799047 | chr4:90077622-90077623 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147032526 | chr4:90077672-90077673 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572860134 | chr4:90077677-90077678 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs67283932 | chr4:90077718-90077719 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540177273 | chr4:90077721-90077722 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528004778 | chr4:90077741-90077742 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs62304660 | chr4:90077751-90077752 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs114500237 | chr4:90077803-90077804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569148061 | chr4:90077819-90077820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368976645 | chr4:90077823-90077824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138260102 | chr4:90077852-90077853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113078398 | chr4:90077881-90077882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs58717304 | chr4:90077882-90077883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs56325804 | chr4:90077888-90077889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397758687 | chr4:90077895-90077896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552515044 | chr4:90077936-90077937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564566593 | chr4:90077947-90077948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181133322 | chr4:90077950-90077951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79013678 | chr4:90077986-90077987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149144370 | chr4:90078010-90078011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535483781 | chr4:90078061-90078062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550429752 | chr4:90078080-90078081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186572423 | chr4:90078137-90078138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111348265 | chr4:90078179-90078180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374436662 | chr4:90078191-90078192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs149159794 | chr4:90078192-90078193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs57998284 | chr4:90078211-90078212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs56289964 | chr4:90078213-90078214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs6831818 | chr4:90078219-90078220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369438632 | chr4:90078221-90078222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200985448 | chr4:90078252-90078253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539578168 | chr4:90078263-90078264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35160360 | chr4:90078273-90078274 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs566704479 | chr4:90078280-90078281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112739616 | chr4:90078303-90078304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533862555 | chr4:90078310-90078311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555536588 | chr4:90078384-90078385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539909123 | chr4:90078432-90078433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs202057908 | chr4:90078433-90078434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573658427 | chr4:90078442-90078443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs11737657 | chr4:90078476-90078477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:90070200-90079000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr4:90074600-90078800 | Weak transcription | A549 | lung |
3 | chr4:90077400-90077600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr4:90077600-90077800 | Bivalent Enhancer | Stomach Mucosa | stomach |
5 | chr4:90077800-90079000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr4:90078800-90079000 | Enhancers | A549 | lung |
7 | chr4:90079000-90079400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr4:90079000-90079400 | Active TSS | Breast Myoepithelial Primary Cells | Breast |
9 | chr4:90079000-90079400 | Weak transcription | A549 | lung |
10 | chr4:90079000-90085200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr4:90079400-90080000 | Enhancers | A549 | lung |
12 | chr4:90079600-90079800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr4:90079600-90079800 | Enhancers | Fetal Lung | lung |
14 | chr4:90079800-90080200 | Active TSS | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr4:90079800-90080200 | Active TSS | Brain Anterior Caudate | brain |
16 | chr4:90079800-90080200 | Active TSS | Brain Hippocampus Middle | brain |
17 | chr4:90079800-90080200 | Enhancers | HUVEC | blood vessel |